Hoersholm building 2


Novozymes and Chr. Hansen have joined forces to create Novonesis, a leading biosolutions partner. Working closely with our customers, we’re transforming the way the world produces, consumes and lives. 

To visit Novonesis.com, please click below:


Financial calendar

Novonesis will provide a Q1 trading statement on May 3, 2024.

Company announcements and news

Share this with: